Business
Currency:GBP
2023/FY
Stock NameRevenueRatio
The Development of cell-based therapies530K100.00%
Region
Currency:GBP
2023/FY
Stock NameRevenueRatio
Income associated with development activities394K74.34%
Royalty Income136K25.66%